Tag Archives: Merck
By Pharm Exec | Published: February 20, 2014
Four class representatives have been added to a class-action gender-discrimination employment suit originally filed last May against Merck & Co. in New Jersey.
By Marylyn Donahue | Published: November 20, 2013
The radical shift currently taking place in pharma marketing is all about partnering with patients rather than talking at them. In other words, pharma and patients are becoming friends who can help their “partners” educate, design a diet plan, increase disease awareness, and take you to the doctor…well, not quite yet.
By William Looney | Published: November 13, 2013
Big Pharma is quietly stepping up to provide critical supplies of essential medicines, other health equipment, and skilled local personnel to areas of the Philippines devastated by Typhoon Haiyan this month. Although industry operations in the Philippines appear largely intact, most companies are working through global humanitarian aid organizations due to the logistical challenges created […]
By Ben Comer | Published: August 1, 2013
Eight months into the launch of its first approved drug – Iclusig (ponatinib), a small molecule therapy indicated for two rare forms of leukemia – Ariad Pharmaceuticals’ principal founder and CEO Harvey Berger says doing it all, from discovery to global commercialization, is the company’s path to sustainability and the way to take on Big […]
By Clark Herman | Published: May 30, 2013
PharmExec sat down with Colleen A. McHorney, PhD, former Senior Scientist at Merck’s U.S. Outcomes Research to review her long record of scientific research on adherence in advance of her retirement last month. McHorney highlights the cyclical nature of engagement on adherence programs, technology’s inherent inadequacies, the need to study the provider as well as […]